Trial intelligence / Profile preview

Intrathecal fentanyl or sufentanil added to ropivacaine for spinal anesthesia in lower limb orthopedic surgery

IRCT20131108015322N8Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Oct 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ropivacaine, fentanyl and sufentanil in pain (4 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Onset of sensory block, Duration of sensory block and 5 more. Started Oct 2024; status: completed.

02

Drugs

ropivacainefentanylsufentanil
03

Conditions

pain

Beyond the preview

Go deeper on IRCT20131108015322N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20131108015322N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call